July 12, 2021 -- Quidel has secured the CE Mark for its Savanna molecular analyzer and its Savanna Respiratory Viral Panel-4 (RVP4) Assay, which will allow the firm to market the system in Europe.
Savanna allows users to analyze 12 pathogens in a single test that lasts less than 30 minutes, according to Quidel. Its Savanna RVP4 Assay is a nucleic acid test to detect influenza, respiratory syncytial virus, and SARS-CoV-2, the company said.
When LabPulse gets hot new information, our Insiders are the first to find out. Stay current in today's competitive market by receiving our exclusive free email updates.Yes, Keep Me Current